Skip to main content
Watch Insiders
RLAYHealthcare

Relay Therapeutics Inc (RLAY) Insider Trading

In the last 90 days, 7 Relay Therapeutics Inc (RLAY) insiders reported no open-market purchases and 11 sales totaling $353,231,901. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 7, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 7, 2026Sanjiv PatelPresident and CEOSale48,199$18.10$872,402
Oct 6, 2026Thomas CatinazzoChief Financial OfficerSale17,717$18.59$329,322
Sep 8, 2026Donald A BergstromPresident, R&DSale8,530$18.97$161,814
Sep 8, 2026Thomas CatinazzoChief Financial OfficerSale17,717$18.94$335,560
Sep 8, 2026Sanjiv PatelPresident and CEOSale48,199$18.94$912,889
Aug 26, 2026Peter RahmerSee remarksSale4,508$20.03$90,295
Aug 25, 2026Sb Investment Advisers (uk) LtdCorporate insiderSale6,000,000$19.40$116,400,000
Aug 25, 2026Softbank Vision Fund (aiv M2) L.P.Corporate insiderSale6,000,000$19.40$116,400,000
Aug 25, 2026SVF Pauling (Cayman) LtdCorporate insiderSale6,000,000$19.40$116,400,000
Aug 17, 2026Sanjiv PatelPresident and CEOSale48,199$20.33$979,886
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

RLAY insider trading FAQ

Are RLAY insiders buying or selling?
Over the last 90 days, RLAY insiders were net sellers, reporting $0.00 of open-market purchases and $353,231,901 of sales.
When was the last RLAY insider purchase?
No open-market insider purchase of Relay Therapeutics Inc stock was reported in the last 90 days.
Where does RLAY insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Relay Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.